IRD
Opus Genetics, Inc. Common Stock
stockNASDAQ
At CloseNov 5, 2026 3:59:58 PM EST
4.01USD-6.316%(-0.27)1,481,279
After-hoursNov 5, 2026 4:41:30 PM EST
3.99USD-0.375%(-0.02)
IRD Financials
In Q2 FY 2026 (ended ), Opus Genetics, Inc. Common Stock (IRD) reported revenue of $755K, net income of −$8.1M, operating cash flow of −$11.95M, and assets of $92.97M (filed ).
Loading financial statements…